SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-19-001061
Filing Date
2019-02-14
Accepted
2019-02-14 11:23:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 AZURRX BIOPHARMA, INC. p19-0280sc13ga.htm SC 13G/A 65505
  Complete submission text file 0000902664-19-001061.txt   67294
Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

IRS No.: 134131516 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-89966 | Film No.: 19602826
SIC: 2834 Pharmaceutical Preparations